miR-760影响充血性肺动脉高压肺动脉肌化改变的机制研究-东南大学学报医学版

miR-760影响充血性肺动脉高压肺动脉肌化改变的机制研究

单位：1. 南京医科大学附属儿童医院药学部, 江苏南京 210019;
2. 南京医科大学附属儿童医院心胸外科, 江苏南京 210019;
3. 南京医科大学附属儿童医院消化外科, 江苏南京 210019

分类号：R543.2

出版年·卷·期（页码）：2019·38·第三期（490-493）

摘要：

目的：探讨微小RNA-760（miR-760）通过调控toll样受体4（TLR4）引起充血性肺动脉高压肺动脉肌化的机制。方法：使用实时定量PCR法检测猪肺动脉平滑肌细胞（PASMCs）和氨基马尿酸处理的PASMCs中miR-760的表达；采用病毒包装载体构建miRNA-760过表达和沉默载体，分别检测对肺动脉平滑肌细胞增殖和下游血小板TLR4蛋白表达的影响。使用双荧光素酶报告基因实验检测miR-760和TLR4基因的靶向性。结果：cPAH-PASMCs组miR-760的表达水平显著低于PASMCs组；外源性上调miR-760可有效抑制TLR4蛋白表达、控制PASMCs增殖；双荧光素酶报告实验显示野生型TLR4基因共转染miR-760过表达载体后荧光素酶活性较PASMCs组显著降低。结论：miR-760可能通过靶向TLR4影响充血性肺动脉高压肺动脉肌化的改变，miR-760可能是充血性肺动脉高压发病的保护因素。

Objective:To investigate the mechanism of pulmonary arterial muscularization in congestive pulmonary hypertension induced by microRNA-760(miR-760) through regulating Toll-like receptor 4(TLR4). Methods:Real-time quantitative polymerase chain reaction was used to detect the expression of miR-760 of porcine pulmonary artery smooth muscle cells(PASMCs) in control group and in aminohippuric acid-treated PASMCs(cPAH-PASMCs) group. The viral packaging vectors were used to construct the overexpression and silencing vectors of miR-760. The effects of miR-760 on the proliferation of PASMCs and the expression of TLR4 protein in downstream platelets were detected. The dual luciferase reporter gene assay was used to detect the targeting of miR-760 and TLR4 genes. Results:The expression level of miR-760 in cPAH-PASMCs group was significantly lower than that in the PASMCs group. Exogenous up-regulation of miR-760 could effectively inhibit the expression of TLR4 protein and control the proliferation of PASMCs. The dual luciferase reporter assay showed that after the wild-type TLR4 gene was cotransfected into the miR-760 overexpression vector, the luciferase activity was significantly lower than that of PASMCs group. Conclusion:miR-760 may affect pulmonary artery muscularization in patients with congestive pulmonary hypertension by targeting TLR4. miR-760 may be a protective factor for the pathogenesis of cPAHs.

参考文献：

[1] 陶慧林,王怀良,郭伟,等.几种药物对肺主动脉平滑肌细胞增殖作用影响的比较研究[J].中国现代应用药学,2005,22(3):187-190.
[2] 石磊,石焱,罗琳.降钙素原在慢性阻塞性肺疾病急性加重期抗感染治疗中临床应用[J].临床军医杂志,2017,45(2):165-168.
[3] DU T,ZAMORE P D.MicroPrimer:the biogenesis and function of microRNA[J].Development,2005,132(21):4645-4652.
[4] ALVAREZ-GARCIA I,MISKA E A.MicroRNA functions in animal development and human disease[J].Development,2005,132(21):4653-4662.
[5] LOVIS P,GATTESCO S,REGAZZI R.Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs[J].Biol Chem,2008,389(3):305-312.
[6] FAVRET S,BINET F,LAPALME E,et al.Deficiency in the metabolite receptor SUCNR1(GPR91) leads to outer retinal lesions[J].Aging,2013,5(6):427-444.
[7] 常文泽,朱鲜阳.肺动脉高压靶向药物治疗现状与进展[J].临床军医杂志,2017,45(6):653-656.
[8] 张鹏飞,徐广全.间充质干细胞分化治疗肺部疾病相关实验的研究进展[J].东南大学学报(医学版),2016,35(2):266-268.
[9] 周昕,廖国庆.Caspase-9在结肠癌化疗前后的表达及意义[J].解剖学研究,2016,38(5):368-370.
[10] CARUSO P,DEMPSIE Y,STEVENS H C,et al.A role for miR-145 in pulmonary arterial hypertension:evidence from mouse models and patient samples[J].Circ Res,2012,111(3):290-300.
[11] PARIKH V N,JIN R C,RABELLO S,et al.MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension:results of a network bioinformatics approach[J].Circulation,2012,125(12):1520-1532.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录